- Home
- Publications
- Publication Search
- Publication Details
Title
Primary tumor–derived systemic nANGPTL4 inhibits metastasis
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 220, Issue 1, Pages -
Publisher
Rockefeller University Press
Online
2022-09-16
DOI
10.1084/jem.20202595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ANGPTL4 influences the therapeutic response of neovascular age-related macular degeneration patients by promoting choroidal neovascularization
- (2022) Yu Qin et al. JCI Insight
- Novel therapeutic targets for cancer metastasis
- (2020) Konstantin Stoletov et al. Expert Review of Anticancer Therapy
- Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
- (2019) Raziye Piranlioglu et al. Nature Communications
- Defining the Hallmarks of Metastasis
- (2019) Danny R. Welch et al. CANCER RESEARCH
- Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema
- (2019) Akrit Sodhi et al. JOURNAL OF CLINICAL INVESTIGATION
- Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study
- (2019) Gilles R Dagenais et al. LANCET
- Are 90% of deaths from cancer caused by metastases?
- (2019) Hanna Dillekås et al. Cancer Medicine
- Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis
- (2018) T. Zhang et al. BMC CANCER
- Potential impact of invasive surgical procedures on primary tumor growth and metastasis
- (2018) Maria Alieva et al. CLINICAL & EXPERIMENTAL METASTASIS
- Knockdown of angiopoietin-like 4 inhibits the development of human gastric cancer
- (2018) Jin-Wu Chen et al. ONCOLOGY REPORTS
- The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
- (2018) Jordan A. Krall et al. Science Translational Medicine
- A review of the multifunctionality of angiopoietin-like 4 in eye disease
- (2018) Xinyue Yang et al. BIOSCIENCE REPORTS
- Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
- (2018) Ryan Kolb et al. ONCOGENE
- OTP: An automatized system for managing and processing NGS data
- (2017) Eva Reisinger et al. JOURNAL OF BIOTECHNOLOGY
- Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway
- (2017) Laura La Paglia et al. PPAR Research
- ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis
- (2017) Sivan Izraely et al. Oncotarget
- Primary Tumors Limit Metastasis Formation through Induction of IL15-Mediated Cross-Talk between Patrolling Monocytes and NK Cells
- (2017) Hiroshi Kubo et al. Cancer Immunology Research
- Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines
- (2017) Koichi Baba et al. Scientific Reports
- Significance of Tissue Expression and Serum Levels of Angiopoietin-like Protein 4 in Breast Cancer Progression: Link to NF-κB /P65 Activity and Pro-Inflammatory Cytokines
- (2016) Noha M Shafik et al. Asian Pacific Journal of Cancer Prevention
- ANGPTL4-αvβ3 interaction counteracts hypoxia-induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2
- (2016) Elisa Gomez Perdiguero et al. JOURNAL OF PATHOLOGY
- Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
- (2016) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinoma
- (2016) Y-H Liao et al. ONCOGENE
- Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma
- (2016) Ke Hu et al. Oncotarget
- Novel endogenous angiogenesis inhibitors and their therapeutic potential
- (2015) Nithya Rao et al. ACTA PHARMACOLOGICA SINICA
- Angiopoietin-like 4 Increases Pulmonary Tissue Leakiness and Damage during Influenza Pneumonia
- (2015) Liang Li et al. Cell Reports
- Endothelial cell-derived non-canonical Wnt ligands control vascular pruning in angiogenesis
- (2014) C. Korn et al. DEVELOPMENT
- Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma
- (2014) Kevin Tak-Pan Ng et al. Molecular Cancer
- Regulation of lipoprotein lipase by Angptl4
- (2014) Wieneke Dijk et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Syndecan-4 signaling at a glance
- (2013) A. Elfenbein et al. JOURNAL OF CELL SCIENCE
- ANGPTL4 is a secreted tumor suppressor that inhibits angiogenesis
- (2013) E Okochi-Takada et al. ONCOGENE
- Concomitant tumor resistance
- (2012) Paula Chiarella et al. CANCER LETTERS
- Emerging Roles of Angiopoietin-like 4 in Human Cancer
- (2012) Ming Jie Tan et al. MOLECULAR CANCER RESEARCH
- Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer
- (2012) Rong Biaoxue et al. World Journal of Surgical Oncology
- ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters
- (2011) R.-L. Huang et al. BLOOD
- Angiopoietin-like 4 Protein Elevates the Prosurvival Intracellular O2−:H2O2 Ratio and Confers Anoikis Resistance to Tumors
- (2011) Pengcheng Zhu et al. CANCER CELL
- Protection Against Myocardial Infarction and No-Reflow Through Preservation of Vascular Integrity by Angiopoietin-Like 4
- (2011) Ariane Galaup et al. CIRCULATION
- Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β1 signaling in human hepatocellular carcinoma
- (2011) Hong Li et al. HEPATOLOGY
- Proteolytic Processing of Angiopoietin-like Protein 4 by Proprotein Convertases Modulates Its Inhibitory Effects on Lipoprotein Lipase Activity
- (2011) Xia Lei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Use of the mouse aortic ring assay to study angiogenesis
- (2011) Marianne Baker et al. Nature Protocols
- Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis
- (2011) Nakayama ONCOLOGY REPORTS
- A Mouse Model of the Cornea Pocket Assay for Angiogenesis Study
- (2011) Zhongshu Tang et al. Jove-Journal of Visualized Experiments
- Angiopoietin-Like 4 Interacts with Integrins β1 and β5 to Modulate Keratinocyte Migration
- (2010) Yan Yih Goh et al. AMERICAN JOURNAL OF PATHOLOGY
- Expression of angiopoietin-like 4 and tenascin C but not cathepsin C mRNA predicts prognosis of oral tongue squamous cell carcinoma
- (2010) Zhuomin Wang et al. BIOMARKERS
- Clinicopathological significance of angiopoietin-like protein 4 expression in oesophageal squamous cell carcinoma
- (2010) K. Shibata et al. JOURNAL OF CLINICAL PATHOLOGY
- Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion
- (2010) Nakayama ONCOLOGY REPORTS
- Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma
- (2010) T. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activating Peroxisome Proliferator-Activated Receptor Mutant Promotes Tumor Growth In vivo by Enhancing Angiogenesis
- (2009) L. Tian et al. CANCER RESEARCH
- Vascular morphogenesis: a Wnt for every vessel?
- (2009) Claudio Areias Franco et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4
- (2008) David Padua et al. CELL
- Molecular Basis of Metastasis
- (2008) Anne C. Chiang et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started